STEM CELL THERAPEUTIC

Nikkei Japan Reports the Status of MEDIPOST’s Stem Cell Research

43% Increase in Dosage of CARTISTEM, for 4th Quarter of 2014 Year on Year

MEDIPOST will set up a joint venture company in China

Korean stem cells regenerate coach Hiddink’s worn-out knee cartilage

Lung disease stem cell treatment drug ‘PNEUMOSTEM’ application for US clinical trial

Lung disease stem cell drug designated ‘orphan drug in development stage’

Stem Cell Drug ‘CARTISTEM’ Treatment Japanese Patent

US patent for ‘CARTISTEM’ raw material stem cell differentiation capability selection technology

Successful administration of stem cell dementia treatment drug ‘NEUROSTEM’

Japan patent for dementia treatment technology using stem cell

Stem cell treatment ‘CARTISTEM’ patient cutting the 10 million line

Stem cell cartilage differentiation technology Singapore patent